MENLO
PARK, Calif., Dec. 27,
2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a
leading developer of high-quality, highly accurate sequencing
solutions, announced today that management will be presenting at
the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 1:30 PM PT (4:30 PM
ET) in San Francisco,
California.
A live webcast of the event can be accessed at the company's
investors page at investor.pacificbiosciences.com. A replay of the
webcast will be available for at least 30 days following the
event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology
company that designs, develops, and manufactures advanced
sequencing solutions to help scientists and clinical researchers
resolve genetically complex problems. Our products and technologies
stem from two highly differentiated core technologies focused on
accuracy, quality, and completeness, which include our HiFi
long-read sequencing and our SBB® short-read sequencing
technologies. Our products address solutions across a broad set of
research applications, including human germline sequencing, plant
and animal sciences, infectious disease and microbiology, oncology,
and other emerging applications. For more information, please visit
www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use
in diagnostic procedures.
Contacts
Investors:
Todd
Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-present-at-42nd-annual-jp-morgan-healthcare-conference-302022903.html
SOURCE Pacific Biosciences of California, Inc.